LONDON, June 18, 2018 /PRNewswire/ --
GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael Koslowski, MD, as Chief Medical... |